Log In
Print
BCIQ
Print
Print this Print this
 

AZD9291

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionOral irreversible inhibitor of EGFR-activating and resistance mutations
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today